Genericart Metformin+Voglibose 500mg/0.3mg Tablet SR
Marketer
Swast Aushadhi Seva Generic Medicine Store
Salt Composition
Metformin (500mg) + Voglibose (0.3mg)
Overview Genericart Metformin+Voglibose 500mg/0.3mg Tablet SR
Diabetics using the combined medication Metformin/Voglibose 500mg/0.3mg (Genericart SR) should understand it's an antidiabetic agent for managing type 2 diabetes in adults. This dual-action formula regulates blood glucose. Always take this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this is one component of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Possible temporary side effects include nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin reactions. Persistent or concerning side effects warrant immediate medical attention; your doctor can offer management strategies. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, or severe liver/kidney disease. Individuals with a history of heart problems should inform their physician before commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring, along with periodic blood tests for cell counts and liver function, are essential.
Uses of Genericart Metformin+Voglibose 500mg/0.3mg Tablet SR
Managing type 2 diabetes
Major Benefits of Genericart Metformin+Voglibose 500mg/0.3mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Genericart Metformin+Voglibose 500mg/0.3mg Extended-Release tablets should be administered with meals.
Common Side effects of Genericart Metformin+Voglibose 500mg/0.3mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Genericart Metformin+Voglibose 500mg/0.3mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or dividing it. Genericart Metformin+Voglibose 500mg/0.3mg Extended-Release tablets should be administered with meals.
How Genericart Metformin+Voglibose 500mg/0.3mg Tablet SR works:
Metformin and Voglibose 500mg/0.3mg Extended-Release Tablets (Genericart) offer a dual-action approach to diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Genericart Metformin+Voglibose 500mg/0.3mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The combination medication Metformin and Voglibose (500mg/0.3mg sustained-release tablets) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The combination medication Metformin and Voglibose (Genericart brand, 500mg/0.3mg sustained-release tablets) is likely not safe for breastfeeding mothers. Studies in humans indicate potential transfer of the drug into breast milk, posing a risk to the infant.
DrivingSAFE
Metformin and Voglibose (Genericart 500mg/0.3mg SR tablets) typically do not impair driving ability. Nevertheless, individuals using this medication concurrently with other diabetes treatments like sulfonylureas, insulin, or repaglinide should be aware of the increased potential for low blood sugar.
KidneyCAUTION
Metformin and voglibose combination tablets (500mg/0.3mg sustained-release) require careful consideration in individuals with impaired kidney function. Dosage modification may be necessary. Physician consultation is recommended. This medication is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is advised during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Genericart Metformin/Voglibose 500mg/0.3mg extended-release tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Genericart Metformin+Voglibose 500mg/0.3mg Tablet SR :
Should you forget a dose of Genericart Metformin+Voglibose 500mg/0.3mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Genericart Metformin+Voglibose 500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
3,018 People bought this recently